HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Tristar

This article was originally published in The Rose Sheet

Executive Summary

Tristar: Cites expenses relating to the firm's merger with Eurostar Perfumes in explaining its net loss of $1.4 mil. in the fourth quarter (ended Aug. 31) compared to a $270,000 loss the year before. Operating income rose 64.3% to $613,000 in the quarter, while sales decreased 3.2% to $12.3 mil., the firm says Nov. 6. Both the 1995 and restated 1994 figures include the effect of the Eurostar business -- Tristar merged with Eurostar on Aug. 31 ("The Rose Sheet" Sept. 11, In Brief). For the year, Tristar posted a net loss of $932,000, compared to net earnings of $1.4 mil. in fiscal 1994. Sales dropped 12.7% to $44.7 mil. for the twelve months...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002189

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel